BSE Live
Dec 26, 16:01Prev. Close
5563.80
Open Price
5563.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:56Prev. Close
5566.00
Open Price
5539.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5535.00 (39)
| Key Financial Ratios of Alkem Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 36.70 | 36.80 | 39.00 | 36.10 | 26.90 | |
| Diluted EPS (Rs.) | 36.70 | 36.80 | 39.00 | 36.10 | 26.90 | |
| Cash EPS (Rs.) | 41.70 | 403.79 | 420.40 | 384.41 | 291.80 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 259.37 | 2,270.03 | 1,925.37 | 1,558.32 | 1,220.51 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 259.37 | 2,270.03 | 1,925.37 | 1,558.32 | 1,220.51 | |
| Dividend / Share(Rs.) | 4.00 | 20.00 | 20.00 | 20.00 | 15.00 | |
| Revenue from Operations/Share (Rs.) | 266.24 | 2,234.87 | 1,923.84 | 1,612.88 | 1,366.21 | |
| PBDIT/Share (Rs.) | 49.67 | 470.91 | 499.35 | 452.43 | 352.66 | |
| PBIT/Share (Rs.) | 44.68 | 435.18 | 469.23 | 429.07 | 330.04 | |
| PBT/Share (Rs.) | 38.61 | 364.72 | 402.99 | 384.36 | 298.78 | |
| Net Profit/Share (Rs.) | 36.71 | 368.06 | 390.28 | 361.05 | 269.18 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 18.65 | 21.07 | 25.95 | 28.05 | 25.81 | |
| PBIT Margin (%) | 16.78 | 19.47 | 24.39 | 26.60 | 24.15 | |
| PBT Margin (%) | 14.50 | 16.31 | 20.94 | 23.83 | 21.86 | |
| Net Profit Margin (%) | 13.78 | 16.46 | 20.28 | 22.38 | 19.70 | |
| Return on Networth / Equity (%) | 14.15 | 16.21 | 20.27 | 23.16 | 22.05 | |
| Return on Capital Employed (%) | 13.47 | 15.39 | 18.72 | 20.80 | 20.13 | |
| Return on Assets (%) | 9.01 | 10.47 | 11.63 | 13.63 | 12.52 | |
| Total Debt/Equity (X) | 0.35 | 0.33 | 0.52 | 0.43 | 0.50 | |
| Asset Turnover Ratio (%) | 65.40 | 63.61 | 57.36 | 60.92 | 63.55 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.11 | 0.98 | 1.31 | 1.11 | 1.53 | |
| Quick Ratio (X) | 0.77 | 0.61 | 1.01 | 0.83 | 1.29 | |
| Inventory Turnover Ratio (X) | 5.81 | 5.30 | 5.08 | 6.24 | 7.17 | |
| Dividend Payout Ratio (NP) (%) | 10.89 | 5.43 | 5.12 | 5.53 | 5.56 | |
| Dividend Payout Ratio (CP) (%) | 9.59 | 4.95 | 4.75 | 5.20 | 5.13 | |
| Earnings Retention Ratio (%) | 89.11 | 94.57 | 94.88 | 94.47 | 94.44 | |
| Cash Earnings Retention Ratio (%) | 90.41 | 95.05 | 95.25 | 94.80 | 94.87 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 89.10 | 94.56 | 94.87 | 94.46 | 94.43 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key